N-(2-aminoethyl)-5-(2-{[4-(morpholin-4-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)pyridine-3-carboxamide (S25) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.11
Number of clusters 25
Number of clusters representing 95% 8
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.3098
ΔGstrain (kcal/mol) 0.2887
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 1783 0 3.0313
2 1686 0.0331 2.0596
3 1265 0.2032 2.5862
4 1264 0.2037 2.4259
5 1095 0.2887 2.0038
6 966 0.3629 2.5295
7 925 0.3886 2.3012
8 454 0.8100 2.0465
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)